Related Experiment Video

Updated: Jun 13, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

[Stat3 antisense oligodeoxynucleotide induces apoptosis in laryngeal carcinoma cells by regulating apoptosis-related

Haili Lü1, Qiuhang Zhang, Bo Yan

  • 1Department of Otolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital University of Medical Science, Beijing, 100053, China. lvhaili@hotmail.com

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery
|April 29, 2010
PubMed
Abstract

Insights

Stat3 antisense oligodeoxynucleotide (ASODN) induces apoptosis in laryngeal carcinoma cells. This involves increasing Bax and decreasing Bcl-2 and C-Myc expression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Context:

  • Laryngeal carcinoma is a significant health concern.
  • Understanding apoptosis mechanisms is crucial for cancer therapy.
  • Signal transducer and activator of transcription 3 (Stat3) is implicated in cancer progression.

Purpose:

  • To investigate the apoptotic mechanism of Stat3 antisense oligodeoxynucleotide (ASODN) in laryngeal carcinoma cells.
  • To determine the effect of Stat3 ASODN on key apoptosis-related genes.

Summary:

  • Stat3 ASODN was delivered into Hep-2 laryngeal carcinoma cells via lipofection.
  • Western blot and PCR analysis revealed that Stat3 ASODN significantly upregulated Bax expression.
  • Conversely, Stat3 ASODN downregulated Bcl-2 and C-Myc expression in a dose-dependent manner.

Impact:

  • Stat3 ASODN demonstrates potential as a therapeutic agent for laryngeal carcinoma.
  • The study elucidates a novel pathway for inducing apoptosis in cancer cells.
  • Findings contribute to the development of targeted cancer therapies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...